Efficacy of revefenacin, a long-acting muscarinic antagonist for nebulized therapy, in patients with markers of more severe COPD: a post hoc subgroup analysis

Overview of attention for article published in BMC Pulmonary Medicine, May 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

So far, Dimensions has found 4 publications that cite this research output.

Article in Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation (March 2024)

Article in American Journal of Health-System Pharmacy (April 2021)

Article in Journal of Experimental Pharmacology (December 2020)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.